Every SEC Form 3/4/5 on record for this filer (CIK 1270354) — 1 issuer, 8 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| XERS | Xeris Biopharma Holdings, Inc. | Director | 2018-06-20 → 2026-06-05 | 14 | −$201,045 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| XERS | 2026-06-03 | Sell | 15,500 | $5.90 | $91,450 | 126,500 |
| XERS | 2025-09-11 | Sell | 15,500 | $7.72 | $119,660 | 142,000 |
| XERS | 2023-11-14 | Buy | 6,370 | $1.58 | $10,065 | 6,370 |
1 of 1 issuers are covered and open a security page; the rest are on file here only.